Women undergoing cancer treatment are more vulnerable.

On Tuesday, the stock hit a low of Rs 2,250 on BSE, down 10 per cent. With this, the scrip has fallen 24 per cent from November 2021 high o...

Now, a team of researchers who followed more than 200 patients for two to three months after their COVID diagnoses report that they have id...

Tatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5757.71 Crore) operating i...

The step, seen as an indicator of growth prospects by investors, send the company’s scrip shooting up to a high of Rs 2,599.90 on the Natio...

Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial diagnosis, according t...

The company's revenue from operations during the second quarter of the financial year 2021-22 (Q2FY22) surged 105.8 per cent YoY to Rs 123....

The strong listing was in line with the recent trend, wherein market debutants have delivered 50-100 per cent returns at listing.

The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and ...